INS Ecosystem

by INS Ecosystem

(0)
View Profile

Ambrosus

by

(0)
View Profile

BlockPharma

by BlockPharma

(0)
View Profile

INS Ecosystem

by INS Ecosystem

(0)
View Profile

Ambrosus

by

(0)
View Profile

BlockPharma

by BlockPharma

(0)
View Profile

What problem does this service solve?

INS Ecosystem wants to use blockchain to improve the heavily monopolized grocery industry by connecting manufacturers directly to consumers. By using smart contracts and a native token, the company hopes to remove intermediaries, reduce prices, and improve supply chains.Ambrosus is building a decentralized supply chain protocol connected with sensors. Their goal is to improve supply chains in industries where maintaining safety and security are important.Blockpharma hopes to improve the process of verifying the authenticity of medications.

Token Stats

Not Relevant

Company Description

The company is building a direct to consumer ecosystem for groceries. Their goal is to create a blockchain-based platform that will enable consumers to buy groceries directly from manufacturers, with lower prices and greater convenience. The INS Ecosystem will allow manufacturers to sell products directly to consumers and reward customer loyalty. The INS token and smart contracts will be used to facilitate exchanges and for tracking purposes. The project has attracted interest from several large manufacturers and the company plans on testing the platform in large metropolitan markets.

Ambrosus is a blockchain-based protocol that tracks and secures supply chain data. Ambrosus uses a system of sensors to track individual items through their entire manufacturing and delivery process. Information about each item and its surroundings can be stored and transmitted to ensure the supply chain, guarantee quality, and prevent tampering. The system is fueled by the AMB token and smart contracts are used for counter-party agreements.

BlockPharma is developing blockchain-based platform to fight drug counterfeiting. Blockpharma's App tracks the origins of medications from their production to their point of sale. They hope to use their technology to identify counterfeits and generally improve the supply chain of the industry.

Ratings

(0)

(0)

(0)